scispace - formally typeset
Search or ask a question

Showing papers in "Zeitschrift Fur Kristallographie-new Crystal Structures in 2012"


Journal ArticleDOI
TL;DR: In this article, the orthorhombic Fdd2 (no. 43) was used to construct the orthogonal homomorphism of the orthorehombics.
Abstract: C16H11BrClNO2, orthorhombic, Fdd2 (no. 43), a = 25.301(1)Å, b = 51.746(2) Å, c = 4.5806(2) Å, V = 5997.0 Å, Z = 16, Rgt(F) = 0.031, wRref(F ) = 0.066, T = 296 K.

14 citations


Journal ArticleDOI
TL;DR: In this paper, the orthorhombic orthogonality was investigated and the authors found that the number of orthorehombics is larger than 7.6061(6) Å, b = 9.4475(8)Å, c = 21.693(2)À, V = 1558.8 Å.
Abstract: C16H10BrCl2NO2, orthorhombic, P212121 (no. 19), a = 7.6061(6) Å, b = 9.4475(8) Å, c = 21.693(2) Å, V = 1558.8 Å, Z = 4, Rgt(F) = 0.039, wRref(F ) = 0.089, T = 296 K.

12 citations


Journal ArticleDOI
TL;DR: In this article, the authors proposed a monoclinear approach for monoclonelithmography and showed that it is possible to construct a monocallinic P121/c1 (no. 14), a = 5.2239(4) Å, b = 14.573(1)Å, c = 29.272(2)
Abstract: C22H28N2O6, monoclinic, P121/c1 (no. 14), a = 5.2239(4) Å, b = 14.573(1) Å, c = 29.272(2) Å, ) = 92.714(1)°, V = 2225.9 Å, Z = 4, Rgt(F) = 0.060, wRref(F ) = 0.136, T = 298 K.

12 citations


Journal ArticleDOI
TL;DR: In this article, a = 15.723(2) Å, b = 13.965(1)Å, c = 6.1959(4)À, ) = 96.096°, V = 1352.7 Å.
Abstract: C15H13BrN2O2, monoclinic, P121/c1 (no. 14), a = 15.723(2) Å, b = 13.965(1) Å, c = 6.1959(4) Å, ) = 96.096(1)°, V = 1352.7 Å, Z = 4, Rgt(F) = 0.039, wRref(F ) = 0.089, T = 298 K.

10 citations


Journal ArticleDOI
TL;DR: Ba3N8O6P6, trigonal, P3 (no. 147), a = 7.40227(9) A, c = 6.3144(1) A , V = 299.6 A3, Z = 1, R(I) = 0.008, R (P) =0.041, T = 297(2) K.
Abstract: Ba3N8O6P6, trigonal, P3 (no. 147), a = 7.40227(9) A, c = 6.3144(1) A, V = 299.6 A3, Z = 1, R(I) = 0.008, R(P) = 0.041, T = 297(2) K.

7 citations


Journal ArticleDOI
TL;DR: In this article, Lu is coordinated by six oxygen atoms from six ligands and one terminal coordinated water molecule, and each BTC ligand coordinates six Lu with dimonodentate mode.
Abstract: C9H5LuO7, tetragonal, P4122 (no. 91), a = 10.225(1) Å, c = 14.369(3) Å, V = 1502.1 Å, Z = 8, Rgt(F) = 0.036, wRref(F ) = 0.125, T = 293 K. Source of material A clear solution of Lu(NO3)3 $ nH2O (40 mg, 0.10 mmol), 1,3,5benzenetricarboxylic acid (H3BTC, 20 mg, 0.10 mmol), DMF (10 ml) and H2O (4 ml) was left at 85 °C for 10 hours to give colorless rod-shaped crystals. They were washed with 10 mL methanol three times and dried in air (yield 65 %, based on H3BTC). The samples were stable in air and insoluble in common organic solvents such as acetone, methanol, ethanol, dichloromethane and DMF. Experimental details The Flack parameter is –0.08(5). Water H atoms have not been included in the refinement. Discussion In the title crystal structure, each rare earth metal Lu is coordinated by six oxygen atoms from six ligands and one terminal coordinated water molecule, and each BTC ligand coordinates six Lu with dimonodentate mode. Lu connect with each other through carboxylates to form one-dimensional chiral lines along [001] direction, which can be defined as rod SBUs (second building units). Each rod SBU connects to others through BTC ligands along [100] and [010] directions to further construct three-dimensional frameworks. There are one-dimensional circular channels (approximately 6 \" 6 Å) in the frameworks along the [001] direction, after the terminal coordinated water molecules have been removed. Z. Kristallogr. NCS 227 (2012) 91-92 / DOI 10.1524/ncrs.2012.0041 91 © by Oldenbourg Wissenschaftsverlag, München Crystal: colorless rod, size 0.3 \" 0.3 \" 0.8 mm Wavelength: Mo K, radiation (0.71073 Å) /: 65.87 cm Diffractometer, scan mode: Bruker APEX-II CCD, #/& 2-max: 56.6° N(hkl)measured, N(hkl)unique: 9550, 1787 Criterion for Iobs, N(hkl)gt: Iobs > 2 *(Iobs), 1630 N(param)refined: 80 Programs: SHELXS-97, SHELXL-97 [2] Table 1. Data collection and handling. H(3) 8d 1.079 0.4415 0.129 0.027 H(5) 4a 1 0.1000 0 0.026 Table 2. Atomic coordinates and displacement parameters (in Å). Atom Site x y z Uiso _____________ * Correspondence author (e-mail: lizhongyue@hpu.edu.cn) Lu(1) 4c 1.14819(3) 2–x 8 0.0174(2) U11 0.0116(2) #0.0016(2) 0.0001(2) U13 C(1) 4a 1 0.613(1) 0 0.030(7) 0.015(6) 0.028(7) 0 #0.006(6) 0 C(2) 4a 1 0.463(1) 0 0.041(8) 0.008(6) 0.024(7) 0 #0.008(6) 0 C(3) 8d 1.047(1) 0.3959(9) 0.0779(7) 0.034(5) 0.018(4) 0.015(4) 0.004(4) #0.007(4) #0.001(3) C(4) 8d 1.044(1) 0.259(1) 0.0781(6) 0.037(6) 0.016(5) 0.018(4) 0.000(4) #0.002(4) 0.002(4) C(5) 4a 1 0.191(1) 0 0.034(8) 0.017(6) 0.015(6) 0 #0.009(6) 0 C(6) 8d 1.089(1) 0.181(1) 0.1613(7) 0.024(5) 0.024(5) 0.021(4) 0.006(4) #0.005(4) 0.002(4) O(1) 8d 1.0732(9) 0.6665(7) 0.0581(6) 0.057(6) 0.019(4) 0.035(4) #0.003(4) #0.016(4) #0.006(3) Table 3. Atomic coordinates and displacement parameters (in Å). Atom Site x y z U11 U22 U33 U12 U13 U23

5 citations


Journal ArticleDOI
TL;DR: In this paper, a monoclinic approach was proposed for monoclonal cancer detection using monocular microscopy, and β = 109.824(8)°, V = 2928.6 Å3, Z = 4, Rgt(F) = 0.0811, wRref(F2) =0.2123, T = 293 K.
Abstract: Abstract C23H25MnN9NiOS4, monoclinic, P21/c (no. 14), a = 19.48(1) Å, b = 7.462(4) Å, c = 21.41(1) Å, β = 109.824(8)°, V = 2928.6 Å3, Z = 4, Rgt(F) = 0.0811, wRref(F2) = 0.2123, T = 293 K.

5 citations


Journal ArticleDOI
TL;DR: In this paper, the triclinic triconnectar trichloro-n2O8 (trichlinic) triconvariances were found to be triconvex.
Abstract: C13H17CdN2O8, triclinic, P1 (no. 2), a = 9.230(1) A, b = 10.191(1) A, c = 10.248(1) A, 5 = 65.699(1)°, 4 = 65.896(1)°, 3 = 79.459(1)°, V = 801.8 A, Z = 2, Rgt(F) = 0.0203, wRref(F ) = 0.0490, T = 296 K.

4 citations


Journal ArticleDOI
TL;DR: In this paper, a monoclinic approach was proposed to solve the problem of monoclonal cancer using monocular microscopy, and the results showed that the approach was effective.
Abstract: Abstract C13H12N4O2, monoclinic, Cc (no. 9), a = 8.749(4) Å, b = 17.707(8) Å, c = 8.005(4) Å, β = 102.751(5)°, V = 1209.5 Å3, Z = 4, Rgt(F) = 0.0270, wRref(F2) = 0.0701, T = 296 K

4 citations


Journal ArticleDOI
TL;DR: In this paper, Cmcm (no. 63), a =8.9654, b =1 0.1578, c =9.0110, V =8 20.6 A 3, Z =4, Rgt(F) =0.018, wRref(F 2 ) =0.034, T =2 95 K.
Abstract: YFe2Al10 ,o rthorhombic, Cmcm (no. 63), a =8 .9654(2) A, b =1 0.1578(3) A, c =9 .0110(3) A, V =8 20.6 A 3 , Z =4 , Rgt(F) =0 .018, wRref(F 2 ) =0 .034, T =2 95 K.

4 citations


Journal ArticleDOI
TL;DR: In this article, a monoclinic P21/c (no. 14), a = 7.456, b = 27.667, c = 13.607, β = 104.44(3)°, V = 2718.2 Å3, Z = 4, Rgt(F) = 0.0464, wRref(F2) =0.0938, T = 293 K.
Abstract: Abstract C22H22CdI2N10, monoclinic, P21/c (no. 14), a = 7.456(2) Å, b = 27.667(6) Å, c = 13.607(3) Å, β = 104.44(3)°, V = 2718.2 Å3, Z = 4, Rgt(F) = 0.0464, wRref(F2) = 0.0938, T = 293 K.

Journal ArticleDOI
TL;DR: In this article, the triclinic P1 (no. 2), a = 8.9012(7) Å, b = 10.8414(9)Å, c = 11.831(1)À, * = 92.029(1°, ǫ = 111.222°,'= 109.585°, V = 986.7°, Z = 2, Rgt(F) = 0.056, wRref(F ) =0.183, T = 296 K
Abstract: C22H17F6NO, triclinic, P1 (no. 2), a = 8.9012(7) Å, b = 10.8414(9) Å, c = 11.831(1) Å, * = 92.029(1)°, ) = 111.222(1)°, ' = 109.585(1)°, V = 986.7 Å, Z = 2, Rgt(F) = 0.056, wRref(F ) = 0.183, T = 296 K.

Journal ArticleDOI
TL;DR: In this article, a monoclinic C10H8Cl2N2S2Zn (no. 15), a = 12.317(2) Å, b = 9.868Å, c = 10.947Å and β = 92.37Å.
Abstract: Abstract C10H8Cl2N2S2Zn, monoclinic, C2/c (no. 15), a = 12.317(2) Å, b = 9.868(2) Å, c = 10.947(2) Å, β = 92.37(2)°, V = 1329.3 Å3, Z = 4, Rgt(F) = 0.036, wRref(F2) = 0.132, T = 110 K.

Journal ArticleDOI
TL;DR: In this article, the orthorhombic Pccn (no. 56), a = 23.109(6) Å, b = 15.246Å, c = 17.005Å and V = 5991.2 Å.
Abstract: C24H16Cu2I3N4S4, orthorhombic, Pccn (no. 56), a = 23.109(6) Å, b = 15.246(4) Å, c = 17.005(4) Å, V = 5991.2 Å, Z = 8, Rgt(F) = 0.077, wRref(F ) = 0.232, T = 293 K.

Journal ArticleDOI
TL;DR: In this paper, triclinic trichromatic trichloroethylene (C30H38Cl6Hg3N8O2) was used as a triconnection.
Abstract: C30H38Cl6Hg3N8O2, triclinic, P1 (no. 2), a = 7.3649(5) A, b = 11.4075(8) A, c = 13.0120(9) A, 1 = 100.454(1)°, / = 102.089(1)°, . = 103.229(1)°, V = 1010.0 A, Z = 1, Rgt(F) = 0.0202, wRref(F ) = 0.0502, T = 291 K.

Journal ArticleDOI
TL;DR: In this article, a = 9.973 A, b = 1 1.376 A, c = 1 3.675 A, * = 1 01.53(3)°, ) = 9 9.54(3), ’ = 1 12.05(3)-°, V = 1 358.6 A 3
Abstract: C18H44N6O14 ,t riclinic, P1 (no. 2), a =9 .973(2) A, b =1 1.376(2) A, c =1 3.675(3) A, * =1 01.53(3)°, ) =9 9.54(3)°, ’ =1 12.05(3)°, V =1 358.6 A 3

Journal ArticleDOI
TL;DR: In this article, the triclinic trichloriconic triclinal trichlinic has been used for trichlionic tricline analysis and it is shown that a = 8.8100 A, b = 9.6324 A, c = 14.2606 A, 1 = 104.963°, / = 92.574°,. = 109.713°, V = 1089.0 A, Z = 2, Rgt(F) = 0.0274, wRref(F ) =
Abstract: C8H33N8SbSe4Zn, triclinic, P1 (no. 2), a = 8.8100(2) A, b = 9.6324(2) A, c = 14.2606(4) A, 1 = 104.963(2)°, / = 92.574(2)°, . = 109.713(3)°, V = 1089.0 A, Z = 2, Rgt(F) = 0.0274, wRref(F ) = 0.0711, T = 150 K.

Journal ArticleDOI
TL;DR: In this paper, a = 10.783(1) Å, b = 14.626 (1)Å, c = 9.7936(7) À, ) = 116.877(1 )°, V = 1377.8 Å and T = 298 K.
Abstract: C15H12Cl2N2O2, monoclinic, P121/c1 (no. 14), a = 10.783(1) Å, b = 14.626(1) Å, c = 9.7936(7) Å, ) = 116.877(1)°, V = 1377.8 Å, Z = 4, Rgt(F) = 0.035, wRref(F ) = 0.11, T = 298 K.

Journal ArticleDOI
TL;DR: In this paper, the title complex of 1,3-bis-(1,2,4-triazol-1-yl)propane (btp, 14 mg, 0.1mmol) was obtained.
Abstract: C16H20N6O6Zn, monoclinic, P21/c (no. 14), a = 9.534(1) A, b = 21.463(3) A, c = 10.158(1) A, / = 110.980(1)°, V = 1940.8 A, Z = 4, Rgt(F) = 0.0331, wRref(F ) = 0.0804, T = 296 K. Source of material 1,3-bis-(1,2,4-triazol-1-yl)propane (btp, 14 mg, 0.1mmol), 5methyl isophthal ic acid (H2mip, 18 mg, 0.1mmol) , Zn(OAc)2·2H2O (22 mg, 0.1mmol) and KOH (5.6 mg, 0.1mmol) were added to water (12 ml) in a Teflon-lined stainless steel vessel. The mixture was heated at 433 K for 3 d, and then slowly cooled down to room temperature. Colourless block-shaped crystals of the title complex were obtained.

Journal ArticleDOI
TL;DR: In this paper, a triclinic compound was synthesized by stirring 1-(2-(diethylamino)ethyl)-3-methylimidazolium triflimide and silver oxide in methanol.
Abstract: C24H38Ag2F12N8O8S4, triclinic,P1 (no. 2), a = 9.4438(4) A, b = 9.8561(3) A, c = 12.0065(4) A,5 = 101.606(2)°, 4 = 93.366(2)°, 3 = 92.789(2)°,V = 1090.7 A , Z = 1, Rgt(F) = 0.0347, wRref(F ) = 0.0837, T = 233 K. Source of material The title compound was synthesized by stirring 1-(2-(diethylamino)ethyl)-3-methylimidazolium triflimide [1] and silver oxide in methanol. After filtration, single crystals were grown from the solution at -20°C. Experimental details In the present case, the asymmetric unit contains one half molecule of the dicationic Ag complex and two half units of the triflimide anions. The two triflimide molecules are located near an inversion centre and are disordered in a way which is not consistent with the symmetry operation of the inversion. For the first anion, we have a 1:1 disorder with split atom positions for O1, O2, F1, F2, F3 andO1A,O2A, F1A, F2A, F3A. The nitrogen atom N4 lies near an inversion centre (occupancy 0.5). The complete anion is generated in two ways: S1–C11–O1–O2– F1–F2–F3–N4 connected with the inverted coordinates of S1–C11–O1A–O2A–F1A–F2A–F3A, or S1–C11–O1A–O2A– F1A–F2A–F3A connected with the inverted coordinates of N4–S1–C11–O1–O2–F1–F2–F3. The second anion shows even more disorder: one identical to the first anion, the second due to additional splitting of the SandC-positions. Thus, four positions are possible. The occupancies are 0.75 for S2 andC12; 0.5 forN5, O3, O4, F4, F5, and F6; and 0.25 for O3A, O4A, F4A, F5A, F6A, S3, C13, O5, O6, F7, F8, and F9. With the exception of S3, the atoms of the minor component were refined isotropically. Cation and anions are shown separately for clarity.

Journal ArticleDOI
TL;DR: In this article, a 0.41CdN2O11,t riclinic, P1 (no. 2), a = 1 0.266(2) A, b = 1 1.907(2), c = 1 4.989(2)-A, 5 = 1 04.822(1)°, 4 = 1 08.566(1)-°, 3 = 9 5.923°, V = 1 644.6°, T =2 96 K.
Abstract: C30H41CdN2O11 ,t riclinic, P1 (no. 2), a =1 0.266(2) A, b =1 1.907(2) A, c =1 4.989(2) A, 5 =1 04.822(1)°, 4 =1 08.566(1)°, 3 =9 5.923(2)°, V =1 644.6 A 3 , Z =2 , Rgt(F) =0 .0307, wRref(F 2 ) =0 .0814, T =2 96 K.

Journal ArticleDOI
TL;DR: In this paper, a tetragonal I4/mm (no. 139) was proposed for the first time, where a = 12.108(2) Å, c = 17.516(4) À, V = 2567.9 Å3, Z = 4, Rgt(F) = 0.0371, wRref(F2) =0.0850, T = 293 K.
Abstract: Abstract Bi8Sn2Yb11, tetragonal, I4/mmm (no. 139), a = 12.108(2) Å, c = 17.516(4) Å, V = 2567.9 Å3, Z = 4, Rgt(F) = 0.0371, wRref(F2) = 0.0850, T = 293 K.

Journal ArticleDOI
TL;DR: In this paper, the authors proposed a monoclinic approach to the monoclonality problem and showed that the approach can be used to obtain a higher bound on the number of lesions.
Abstract: C13H8FI2NO, monoclinic, Cc (no. 9), a = 4.549(1) A, b = 35.025(2) A, c = 17.307(1) A, / = 95.255(2)°, V = 2745.6 A, Z = 8, Rgt(F) = 0.0674, wRref(F ) = 0.1701, T = 298 K.

Journal ArticleDOI
TL;DR: In this paper, the authors proposed a method to detect the presence of brain tumors in the human brain using a set of lesions.C34H38MgO2,m onoclinic, P21/c (no. 14), a = 1 0.321(1) A, b = 1 6.365(2) A and c =1 6.981(2 ) A, / = 1 04.615 (2)°, V =2 775.3 A 3, Z =4, Rgt(F) =
Abstract: C34H38MgO2 ,m onoclinic, P21/c (no. 14), a =1 0.321(1) A, b =1 6.365(2) A, c =1 6.981(2) A, / =1 04.615(2)°, V =2 775.3 A 3 , Z =4 , Rgt(F) =0 .0595, wRref(F

Journal ArticleDOI
TL;DR: In this article, KSnBi was synthesized in ar eaction of equimolar amounts of the corresponding elements in a duran ampoule at 723 K, which was cooled with evaporating liquid nitrogen.
Abstract: C14H14 ,t riclinic, P1 (no. 2), a =6 .450(1) A, b =9 .614(2) A, c =9 .712(2) A, 1 =1 12.11(2)°, / =1 00.55(2)°, . =9 9.87(2)°, V =5 29.1 A 3 , Z =2 , Rgt(F) =0 .0536, wRref(F 2 ) =0 .1610, T =1 23 K. Source of material Al lm anipulations were carried out under argon atmosphere using standard Schlenk techniques. KSnBi was synthesized in ar eaction of equimolar amounts of the corresponding elements in a duran ampoule at 723 K. 367 mg (0.5 mmol) KSnBi and 208 mg (0.5mmol) [(C7H7)Mo(CO)3]PF6 were dissolved in liquid ammonia together with 48 mg (0.13mmol) dibenzo-[18]crown6 (1,4,7,14,17,20-Hexaoxa[7.7]orthocyclophan). Experimental details Crystal preparation was done in perfluoretheroil (Galden HT 230, Fa. Ausimont, USA), which was cooled with evaporating liquid nitrogen. An appropriate crystal was mounted on the nylon loop of the Crystal Cap (CrystalCap Copper 14m mw ith CryoLoop 20’ 0.3-0. 4m m, Hampto nR esearch, USA) an dc haracterized by X-ray diffraction.

Journal ArticleDOI
TL;DR: In this paper, the orthorhombic Pnam (n o. 6 2 ), a = 6.88207, b = 8.26813, c = 5.84767, V = 332.74, Z = 1, Rp = 0.
Abstract: Abstract PbMn0 . 5 Al0 . 5 BO4, orthorhombic, Pnam ( n o . 6 2 ) , a = 6.88207(22) Å, b = 8.26813(31) Å, c = 5.84767(20) Å, V = 332.74 Å3, Z = 1, Rp = 0.0381(i), 0.0458(ii), 0.0505(iii), Rwp = 0.0491(i), 0.0676(ii), 0.0677(iii), T = 298 K.

Journal ArticleDOI
TL;DR: In this article, a monoclinic P21/c (no. 14), a = 9.0703, b = 19.0974, c = 11.9927, β = 120.079(2)°, V = 1797.7 Å3, Z = 4, Rgt(F) = 0.0197, wRref(F2) =0.0464, T = 200 K.
Abstract: Abstract C19H18IP, monoclinic, P21/c (no. 14), a = 9.0703(3) Å, b = 19.0974(6) Å, c = 11.9927(3) Å, β = 120.079(2)°, V = 1797.7 Å3, Z = 4,Rgt(F) = 0.0197, wRref(F2) = 0.0464, T = 200 K.

Journal ArticleDOI
TL;DR: In this article, the triclinic P1 (no. 2) trichloric trichlinic is defined as follows: a = 7.2602(6) Å, b = 8.0823(7)Å, c = 10.6370(9)À,, = 78.774(2)°, + = 70.177(2°,'= 79.724°, V = 571.7
Abstract: C18H20Cl6N2O2Pt, triclinic, P1 (no. 2), a = 7.2602(6) Å, b = 8.0823(7) Å, c = 10.6370(9) Å, , = 78.774(2)°, + = 70.177(2)°, ' = 79.724(2)°, V = 571.7 Å, Z = 1, Rgt(F) = 0.042, wRref(F ) = 0.106, T = 200 K.

Journal ArticleDOI
TL;DR: In this paper, a monoclinic P21/c (no. 14), a = 8.6941(8) Å, b = 12.970(1)Å, c = 21.384(2)À, β = 95.145(1°, V = 2401.5 Å3, Z = 2, Rgt(F) = 0.0376, wRref(F2) =0.0900, T = 296 K.
Abstract: Abstract C52H44MnN10O18, monoclinic, P21/c (no. 14), a = 8.6941(8) Å, b = 12.970(1) Å, c = 21.384(2) Å, β = 95.145(1)°, V = 2401.5 Å3, Z = 2, Rgt(F) = 0.0376, wRref(F2) = 0.0900, T = 296 K.

Journal ArticleDOI
TL;DR: In this paper, a monoclinic P21/n (no. 14), a = 7.5426(2) Å, b = 13.3693(4)Å, c = 20.7286(7) À, ) = 92.020(3)°, V = 2089.0 Å.
Abstract: C20H20N2NiO9, monoclinic, P21/n (no. 14), a = 7.5426(2) Å, b = 13.3693(4) Å, c = 20.7286(7) Å, ) = 92.020(3)°, V = 2089.0 Å, Z = 4, Rgt(F) = 0.033, wRref(F ) = 0.082, T = 296 K.